Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Arrival of Gene Therapy for Patients with Hemophilia A
Giancarlo Castaman, Giovanni Di Minno, Raimondo De Cristofaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10228-10228
Open Access | Times Cited: 18

Showing 18 citing articles:

Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases
Carleigh Sussman, Rachel A. Liberatore, M. Dróżdż
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 535-535
Open Access | Times Cited: 5
Clinical pharmacology of emicizumab for the treatment of hemophilia A
Koichiro Yoneyama, Christophe Schmitt, Agnès Portron, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 9, pp. 775-790
Open Access | Times Cited: 7
Gene therapy for haemophilia A and B, from basic principles to clinical implementation: An illustrated review
Cihan Ay, Laurent Frenzel, Karen Pinachyan, et al.
Haemophilia (2023) Vol. 30, Iss. 1, pp. 5-15
Open Access | Times Cited: 5
Moving towards Normalization of haemostasis and health equity: Evolving treatment goals for haemophilia A
Pål André Holme, Jan Blatný, Pratima Chowdary, et al.
Haemophilia (2024) Vol. 30, Iss. 5, pp. 1109-1114
Closed Access | Times Cited: 1
Bispecific Antibody Format and the Organization of Immunological Synapses in T Cell-Redirecting Strategies for Cancer Immunotherapy
Carlos Carrasco-Padilla, Alicia Hernaiz-Esteban, Luís Álvarez-Vallina, et al.
Pharmaceutics (2022) Vol. 15, Iss. 1, pp. 132-132
Open Access | Times Cited: 9
Toward gene therapy for congenital thrombotic thrombocytopenic purpura
Charlotte Dekimpe, Elien Roose, Kazuya Sakai, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 5, pp. 1090-1099
Open Access | Times Cited: 5
A 360-degree perspective on adeno-associated virus (AAV)-based gene therapy for haemophilia: Insights from the physician, the nurse and the patient
Wolfgang Miesbach, Greta Mulders, Daan Breederveld, et al.
Orphanet Journal of Rare Diseases (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Patient Perspective on Disease Burden and Gene Therapy for Hemophilia A and B: The “Haemvolution for Patients” Italian Survey
Maria Francesca Mansueto, Sarah Bigi, Marco Follino, et al.
Seminars in Thrombosis and Hemostasis (2024)
Closed Access | Times Cited: 1
Hepatitis after gene therapy, what are the possible causes?
A.M. Maina, Graham R. Foster
Journal of Viral Hepatitis (2024) Vol. 31, Iss. S1, pp. 14-20
Open Access
Liver health in hemophilia in the era of gene therapy
Yesim Dargaud, Massimo Levrero, François Bailly, et al.
Thrombosis Research (2024) Vol. 240, pp. 109064-109064
Closed Access
Patient and Caregiver Preferences for Hemophilia A Treatment in Taiwan: A Discrete Choice Experiment
Shyh‐Shin Chiou, Te‐Fu Weng, Jiaan‐Der Wang
Value in Health Regional Issues (2024) Vol. 45, pp. 101035-101035
Open Access
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review
Amr A El-Sayed, Nancy S. Bolous
PharmacoEconomics - Open (2024)
Open Access
A phase 1/2 safety and efficacy study of TAK‐754 gene therapy: The challenge of achieving durable factor VIII expression in haemophilia A clinical trials
John Chapin, María Román, Mila Ayash‐Rashkovsky, et al.
Haemophilia (2024)
Open Access
Terapia Génica como Tratamiento para la Hemofilia
Jennifer Cedillo-Prado, Rosana Córdova-Serrano
593 Digital Publisher CEIT (2023) Vol. 8, Iss. 5, pp. 5-16
Open Access | Times Cited: 1
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context
Jan Astermark, Fariba Baghaei, Karin Strandberg, et al.
Therapeutic Advances in Hematology (2023) Vol. 14
Open Access | Times Cited: 1
CORR Insights®: What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?
Semih Aydoğdu
Clinical Orthopaedics and Related Research (2023) Vol. 481, Iss. 8, pp. 1648-1649
Closed Access
Gene therapy for hemophilia: Current status and future perspectives
Neftali Anguiano Sánchez, Lazalde Brissia
GSC Advanced Research and Reviews (2023) Vol. 15, Iss. 3, pp. 295-303
Open Access
Targeted genome engineering based on CRISPR/Cas9 system to enhance FVIII expression in vitro
Lidong Zhao, Shuai Fang, Yanchun Ma, et al.
Gene (2023) Vol. 896, pp. 148038-148038
Closed Access
Page 1

Scroll to top